Cargando…
Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study
INTRODUCTION: Orchiopexy for congenital cryptorchid testes is recommended between ½ and 1 year of age to preserve testicular germ cell maturation. Early operation is not enough to preserve fertility in 22 and 36% of cases. Aim of this study was to set up a protocol for optional adjuvant hormonal the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996032/ https://www.ncbi.nlm.nih.gov/pubmed/29922233 http://dx.doi.org/10.3389/fendo.2018.00299 |
_version_ | 1783330740766769152 |
---|---|
author | Thorup, Jorgen Clasen-Linde, Erik Dong, Lihua Hildorf, Simone Kristensen, Stine Gry Andersen, Claus Yding Cortes, Dina |
author_facet | Thorup, Jorgen Clasen-Linde, Erik Dong, Lihua Hildorf, Simone Kristensen, Stine Gry Andersen, Claus Yding Cortes, Dina |
author_sort | Thorup, Jorgen |
collection | PubMed |
description | INTRODUCTION: Orchiopexy for congenital cryptorchid testes is recommended between ½ and 1 year of age to preserve testicular germ cell maturation. Early operation is not enough to preserve fertility in 22 and 36% of cases. Aim of this study was to set up a protocol for optional adjuvant hormonal therapy after orchiopexy and thereafter cryopreservation of testicular biopsies from infants with bilateral cryptorchidism and high infertility risk. MATERIALS AND METHODS: We included 17 boys with bilateral cryptorchidism, normal FSH, and impaired germ cell number per tubular transverse section (G/T) in testicular biopsies at orchiopexy, 7 months to 3½ years old. Postoperatively, optional adjuvant LHRH (kryptocur(®)) 0.2 mg/0.1 mL 2× every second day in 16 weeks were offered. Ten boys were applicable for age matching according to parent’s choice of treatment regime and G/T. Five of them had kryptocur(®), and five were controls. Repeat bilateral testicular biopsy evaluation and cryopreservation were offered to all boys 12 months after primary orchiopexy. For cryopreservation, tissue pieces were incubated with a cryoprotectant with a slow program freezing. RESULTS: Two out of five kryptorcur(®)-treated boys normalized both the average G/T and the number of adult dark spermatogonia (Ad-S). Another kryptocur(®)-treated boy with initial low G/T and no Ad-S increased the G/T and achieved normal number of Ad-S at time of cryopreservation. In the control group, two patients reached only normal lower range regarding the G/T and the number of Ad-S. None of boys with less than average 0.2 G/T improved significantly, whether they were kryptocur(®)-treated or not. CONCLUSION: Based on literature and the present results, we recommend adjuvant LHRH treatment to boys with cryptorchidism and insufficient genuine gonadotropin stimulation at time of surgery, as these patients have high infertility risk. Cryopreservation should be an option in case of treatment failure of adjuvant LHRH. However, to avoid repeat surgery with biopsy, some parents may choose biopsy for cryopreservation at time of the initial bilateral orchiopexy, well informed that the procedure may only be truly indicated in 22 and 36% of the cases. |
format | Online Article Text |
id | pubmed-5996032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59960322018-06-19 Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study Thorup, Jorgen Clasen-Linde, Erik Dong, Lihua Hildorf, Simone Kristensen, Stine Gry Andersen, Claus Yding Cortes, Dina Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Orchiopexy for congenital cryptorchid testes is recommended between ½ and 1 year of age to preserve testicular germ cell maturation. Early operation is not enough to preserve fertility in 22 and 36% of cases. Aim of this study was to set up a protocol for optional adjuvant hormonal therapy after orchiopexy and thereafter cryopreservation of testicular biopsies from infants with bilateral cryptorchidism and high infertility risk. MATERIALS AND METHODS: We included 17 boys with bilateral cryptorchidism, normal FSH, and impaired germ cell number per tubular transverse section (G/T) in testicular biopsies at orchiopexy, 7 months to 3½ years old. Postoperatively, optional adjuvant LHRH (kryptocur(®)) 0.2 mg/0.1 mL 2× every second day in 16 weeks were offered. Ten boys were applicable for age matching according to parent’s choice of treatment regime and G/T. Five of them had kryptocur(®), and five were controls. Repeat bilateral testicular biopsy evaluation and cryopreservation were offered to all boys 12 months after primary orchiopexy. For cryopreservation, tissue pieces were incubated with a cryoprotectant with a slow program freezing. RESULTS: Two out of five kryptorcur(®)-treated boys normalized both the average G/T and the number of adult dark spermatogonia (Ad-S). Another kryptocur(®)-treated boy with initial low G/T and no Ad-S increased the G/T and achieved normal number of Ad-S at time of cryopreservation. In the control group, two patients reached only normal lower range regarding the G/T and the number of Ad-S. None of boys with less than average 0.2 G/T improved significantly, whether they were kryptocur(®)-treated or not. CONCLUSION: Based on literature and the present results, we recommend adjuvant LHRH treatment to boys with cryptorchidism and insufficient genuine gonadotropin stimulation at time of surgery, as these patients have high infertility risk. Cryopreservation should be an option in case of treatment failure of adjuvant LHRH. However, to avoid repeat surgery with biopsy, some parents may choose biopsy for cryopreservation at time of the initial bilateral orchiopexy, well informed that the procedure may only be truly indicated in 22 and 36% of the cases. Frontiers Media S.A. 2018-06-05 /pmc/articles/PMC5996032/ /pubmed/29922233 http://dx.doi.org/10.3389/fendo.2018.00299 Text en Copyright © 2018 Thorup, Clasen-Linde, Dong, Hildorf, Kristensen, Andersen and Cortes. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Thorup, Jorgen Clasen-Linde, Erik Dong, Lihua Hildorf, Simone Kristensen, Stine Gry Andersen, Claus Yding Cortes, Dina Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study |
title | Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study |
title_full | Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study |
title_fullStr | Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study |
title_full_unstemmed | Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study |
title_short | Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study |
title_sort | selecting infants with cryptorchidism and high risk of infertility for optional adjuvant hormonal therapy and cryopreservation of germ cells: experience from a pilot study |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996032/ https://www.ncbi.nlm.nih.gov/pubmed/29922233 http://dx.doi.org/10.3389/fendo.2018.00299 |
work_keys_str_mv | AT thorupjorgen selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy AT clasenlindeerik selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy AT donglihua selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy AT hildorfsimone selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy AT kristensenstinegry selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy AT andersenclausyding selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy AT cortesdina selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy |